Long-read genome sequencing has the potential to dramatically impact genetic diagnostics of rare diseases. This Perspective discusses the key challenges and benefits of the technology that will enable its more streamlined clinical implementation.
- Jesper Eisfeldt
- Marlene Ek
- Anna Lindstrand